>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
骨肉瘤保肢综合治疗效果分析
作者:马超1 孙新臣2 
单位:1.东南大学医学院附属徐州医院骨科,江苏,徐州,221009; 2.东南大学(徐州)肿瘤研究所,江苏,徐州,221009
关键词:骨肉瘤 动脉区域灌注 切刮灭活 综合治疗 截肢术 
分类号:R738.7
出版年·卷·期(页码):2004·23·第六期(406-408)
摘要:

目的:探讨骨肉瘤保肢综合治疗的效果.方法:回顾性分析51例骨肉瘤综合治疗的临床资料.32例患者分别行动脉区域灌注灭活和体内切刮灭活手术治疗,19例患者行截肢术.所有病例术前、术后均行化疗.结果:保肢手术3年和5年生存率分别为53.1%和37.5%,与同期截肢术相比无显著性差异(P>0.05);5年内的局部复发率为6.25%;两种保肢术的3年、5年生存率无显著性差异(P>0.05).结论:在综合治疗模式下,保肢和截肢可获得相同的疗效.体内切刮灭活术具有简便、保留骨和关节原有形态及部分功能、并发症少、经济的优点.

Objective  To explore the effects of operation com b ined with chemotherapy for osteogenic sarcoma. Methods   A retro spective analysis  was performed on 51 patients with osteogenic sarcoma treated by limb-preserving  surgery or amputatio n. Thirty-two patients were treated by devitalization and replantation after lo cal arterial p erfusion or intrinsic resection and curettage with devitalization, 19 by amputa t ion. Chemotherapy was given for 6 cycles before and after operation. Res ults  For devitalization and replantation after local arterial perfusion  or intrinsic resecti on and curettage with devitalization, the average postoperative 3-,5-year  survival rate was 53.1%, 37.5%, respectively in 32 patients with osteogenic  sarc oma. Compared with the 19 patients who had amputation owing to osteogenic sarcom a in the same duration, there was no obvious difference of the postoperative 3 - ,5-years survive rate (P>0.05). And also no obvious difference of the 3- ,5 -year survival rates between the two kinds of limb preserving surgery (P>0. 05). The local recurrence rate was 6.25% of limb preserving surgery.  Conclusion  The long term results are the same  in the treatment  of osteogenic sarcoma by limb preserving surgery or amputation, and there are s o me advantages in intrinsic resection and curettage with devitalization, such as  keep ing the original contour and continuity of bone and joint, retaining partial fu n ction of the injured joint, performing easily, less complications and less exp ense.

参考文献:

[1] ABOULAFIA A J, BUCH R, MATHEWS J. Reconstruction using the saddle prosthesis following excision of primary and metastatic periacetabular tumors, 1995
[2] WOLF R E. 3.0.CO, 2-Q.aspx">Sarcoma and metastatic carcinoma. 2000. doi:10.1002/(SICI)1096-9098(200001)73:1&lt, 39::AID-JSO11&gt, 3.0.CO, 2-Q
[3] ENNEKING W F, DUNHAM W, GEBHARDT M C. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculosketetal system, 1993
[4] CAMPANACCI M, LAUS M. Local recurrence after am-putation for osteosarcoma, 1980
[5] ABOULAFIA A J, MALAWER M M. Surgical management of pelvic and extrimity osteosarcoma, 2001
[6] Ham S J. External and internal hemipelvectomy for sarcomas of the pelvic girdle:consequences of limb-salvage treatment, 1997 

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 415083 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364